Young laboratory woman with testtubes

Recent News

July 2019

aTen Therapeutics welcomes Kimberley Meredith on a summer work placement via the University of Edinburgh.

June 2019

aTen Therapeutics attends ‘Outsourcing Clinical Trials’ conference in London.

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

© aTen Therapeutics 2019. All rights reserved